| Customization: | Available |
|---|---|
| Powder: | Yes |
| Customized: | Customized |
|
Still deciding? Get samples of $ !
Request Sample
|
Suppliers with verified business licenses
Audited Supplier Audited by an independent third-party inspection agency
| Product name | Temsirolimus |
| Appearance | Off-white to pale yellow powder |
| CAS NO. | 162635-04-3 |
| MF | C56H87NO16 |
| MW | 1030.303 |
Temsirolimus is an anticancer medication belonging to the class of drugs known as mTOR inhibitors.It is mainly used for the treatment of advanced renal cell carcinoma (kidney cancer) and mantle cell lymphoma.Temsirolimus works by inhibiting the mammalian target of rapamycin (mTOR) kinase, which plays a critical role in cell growth and proliferation. By blocking mTOR, Temsirolimus can slow down or stop the growth of cancer cells, leading to their death.It is typically administered intravenously under the supervision of a healthcare professional.
Temsirolimus is used to treat advanced renal cell carcinoma (RCC, a type of cancer that begins in the kidney). Temsirolimus is in a class of medications called kinase inhibitors. It works by blocking the action of the abnormal protein that tells the cancer cells to multiply. This may help slow the growth of tumors.
){kind=link}